Monitoring the South African National Antiretroviral Treatment Programme, 2003-2007: the Iedea Southern Africa Collaboration (Original Articles) (Report)

Monitoring the South African National Antiretroviral Treatment Programme, 2003-2007: the Iedea Southern Africa Collaboration (Original Articles) (Report)

The World Health Organization (WHO) estimated that in 2007, 9.7 million people in low–and middle-income countries needed antiretroviral treatment (ART), (1) 9% of whom were living in South Africa. (2) By the end of 2007, the South African National Department of Health (DoH) reported that 371 731 people had initiated highly active antiretroviral therapy (HAART), (2) making it the largest ART programme in the world. (1) As the public health system has only provided ART since 2004, this has involved a massive scale-up of services within a comparatively short space of time. In the context of such an ambitious undertaking, trends in enrolment and key outcomes must be understood in order to plan for the changing needs of health services and patients. (1) Monitoring is a major challenge to effective delivery of ART at a national level, (2) and it becomes increasingly important as the continued scale-up of ART creates a tension between service provision and collecting good data.

Monitoring the South African National Antiretroviral Treatment Programme, 2003-2007: the Iedea Southern Africa Collaboration (Original Articles) (Report)

Monitoring the South African National Antiretroviral Treatment Programme, 2003-2007: the Iedea Southern Africa Collaboration (Original Articles) (Report) | | 4.5